HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack second-site EGFRT790M mutation - Takezawa, K; Pirazolli, V; Arcila, M E (Cancer Discov, 2012)
et al.